Y Combinator
Y Combinator, established in 2005, is a prominent American technology startup accelerator and venture capital firm. It provides funding and mentorship to early-stage companies, primarily in the United States. The firm's core program involves investing a small amount of capital in exchange for equity, typically around 6-7%, and providing intensive support to startups over a three-month period. This includes refining business models, developing products, and honing investor pitches. Y Combinator serves a wide range of industries, with a focus on technology, healthcare, and finance. Additionally, Y Combinator Continuity, a dedicated investment fund, supports founders as they scale their companies, investing in later-stage alumni companies and helping cash-intensive businesses.
Past deals in Newfoundland
Sequence Bio
Seed Round in 2019
Sequence Bio is a biotechnology company focused on advancing drug discovery and development through genome therapy. Leveraging the unique genetic characteristics of isolated populations, particularly those in Newfoundland, the company collects DNA and health information to enhance the identification of drug targets. This approach aims to improve the treatment of complex and inherited diseases, ultimately addressing the high failure rate of drug candidates and expediting access to effective therapies for patients in need. By utilizing genetic insights, Sequence Bio seeks to transform the landscape of medicine and deliver better health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.